SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand Pharmaceuticals (LGND)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jay silberman who wrote (10)7/7/1996 6:17:00 PM
From: Henry Niman   of 16
 
The latest issue of PNAS and BioCentury have articles on STAT involvement
in transmission of the signal due to leptin binding to its receptor.
Products from this research are still off in the distant future, but
LGND should have strong patent positions and I'm certain they are in talks
with other larger pharmaceuticals regarding the STAT technology and
ways to profit from the obesity/diabetes/cardiovascular markets.

Henry
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext